Press Contacts

Allison Kurz
Marketing & Communications
+41 61 511 8459
communications@genedata.com

Jackie Thrasivoulos
Public Relations
+1 508 881 3109
jackie.thrasivoulos@genedata.com

Biogas Consortium Using Genedata Selector for Metagenomics-based Process Optimization

Genedata Selector platform to manage, analyze, and integrate complex microbial genomes and strains will be showcased in 5th Annual NGS Conference Poster Session

Munich, Germany, November 19, 2013

Genedata, a leading provider of advanced software solutions for industrial biotechnology, drug discovery, and life science research, today announced its collaboration with GOBI (“General Optimization of BIogasprocesses”), an interdisciplinary  biogas research consortium consisting of leading academic and commercial members to improve the overall efficiency of biogas production. GOBI will be using Genedata SelectorTM to leverage the analysis of high-throughput sequencing data, gene expression data, and genotype-phenotype relationships to optimize their biogas fermentation processes. In addition, this collaboration will provide a centralized knowledge management and analysis platform for the different consortium members. More information about the GOBI project and about how Genedata Selector supports industrial biotechnology and renewable energy workflows will be presented at the 5th Annual Next-Generation Sequencing Conference (November 18-19, London).

"Biologically derived methane – biogas – plays an important role in meeting global energy demands. At the molecular level, the underlying fermentation process is still considered a black box. ” noted GOBI project coordinator Prof. Dr. Joachim Müller (Institute of Agricultural Engineering, University of Hohenheim). “ Understanding this complex process at this level promises a huge optimization potential to increase production yield and diversification such as leveraging waste streams of organic acids for higher value products, specialized fertilizers and sustainable waste management."

“A full understanding of the complete molecular processes in order to optimize microbe populations requires the interpretation of large volumes of complex DNA data representing diverse microbial genomes and strains as well as their RNA data to resolve the transcriptional profile and activities along the fermentation process,” said Dr. Steffen Rupp, Head of Department of Molecular Biotechnology at Fraunhofer IGB Stuttgart. He added “Genedata provides us with a comprehensive, collaborative and secure platform for data management and a central database for proprietary and public sequence data. Beyond that, it gives us bioinformatics tools for next-generation sequencing data analyses, taxonomic profiling of microbial communities, and de-novo discovery of genes, proteins and pathways in biomass degradation.”

Empowering Industrial Biotech R&D
The GOBI project, funded by the German Federal Ministry of Education and Research, demonstrates the efficacy of Genedata Selector as an enterprise-ready platform that empowers research across the entire R&D workflow for industrial biotechnology. It supports NGS-based genome analyses and the complete mapping of sequence, omics, pathway, and phenotype data. Specifically, the system provides GOBI with:

  • Full support of bioprocess engineering: from metagenomics, biomass to microbiome analysis
  • Integrative, scalable, and secure strain management
  • Complete set of software tools including analyses of raw sequencing data, omics data, and statistics
  • Strain analyses tools to optimize feedstock and use of starter cultures in the fermentation process
  • Decision support for production of biogas and bio-based materials



“Genedata is excited to partner with the GOBI consortium and have Genedata Selector contribute to advancing research into renewable energy sources,” said Dr. Othmar Pfannes, CEO of Genedata. “The work with GOBI has applications beyond biogas production, and is an important piece of our strategy to position Genedata Selector as the platform of choice for innovative bio-based products in industries spanning consumer care and cosmetics to fertilizers and feedstock.” 


About Genedata
Genedata transforms data into intelligence with a portfolio of advanced software solutions, which make research data accessible and understandable and research processes more efficient. These solutions are used worldwide by leading pharmaceutical, industrial, and agricultural biotechnology companies as well as academic research organizations. Genedata innovations enable scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Germany, Japan, and the US.

www.genedata.com
Follow Us on LinkedIn


About the Research Project GOBI
GOBI (General Optimization of BIogasprocesses) is an interdisciplinary German biogas research consortium to improve the overall efficiency of biogas production. The project is funded by the German Federal Ministry of Education and Research (BMBF) as part of the program “BioProFi – Bioenergie – Prozessorientierte F&I”. The consortium consists of the following institutes: Agricultural Engineering in the tropics and subtropics; Fertilisation and Soil Matter Dynamics; Biobased Products and Energy Crops; State Institute of Agricultural Engineering and Bioenergy; and Fraunhofer IGB; IS-Forschung Pinneberg; Geltz-Umwelttechnologie GmbH; Agentur für nachhaltige Nutzung von Agrarlandschaften (ANNA); and Genedata.

Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.